Phreesia, Inc. (PHR): Price and Financial Metrics

Phreesia, Inc. (PHR): $15.89

0.26 (+1.66%)

POWR Rating

Component Grades








Add PHR to Watchlist
Sign Up

Industry: Software - Application




#115 of 132

in industry

PHR Price/Volume Stats

Current price $15.89 52-week high $40.00
Prev. close $15.63 52-week low $12.05
Day low $15.73 Volume 469,700
Day high $16.32 Avg. volume 450,337
50-day MA $16.13 Dividend yield N/A
200-day MA $27.24 Market Cap 877.27M

PHR Stock Price Chart Interactive Chart >


  • Sentiment is the dimension where PHR ranks best; there it ranks ahead of 62.64% of US stocks.
  • PHR's strongest trending metric is Value; it's been moving up over the last 177 days.
  • PHR's current lowest rank is in the Stability metric (where it is better than 17.1% of US stocks).

PHR Stock Summary

  • For PHR, its debt to operating expenses ratio is greater than that reported by merely 9.47% of US equities we're observing.
  • PHR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 17.68% of US stocks.
  • Revenue growth over the past 12 months for PHREESIA INC comes in at 30.27%, a number that bests 83.77% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to PHREESIA INC are MXCT, SLGC, TNDM, NTCT, and MASS.
  • Visit PHR's SEC page to see the company's official filings. To visit the company's web site, go to

PHR Valuation Summary

  • In comparison to the median Healthcare stock, PHR's price/earnings ratio is 124.28% lower, now standing at -5.9.
  • PHR's EV/EBIT ratio has moved up 74 over the prior 52 months.

Below are key valuation metrics over time for PHR.

Stock Date P/S P/B P/E EV/EBIT
PHR 2023-11-03 2.8 3.7 -5.9 -5.1
PHR 2023-11-02 2.6 3.4 -5.4 -4.6
PHR 2023-11-01 2.4 3.1 -5.0 -4.2
PHR 2023-10-31 2.4 3.1 -4.9 -4.2
PHR 2023-10-30 2.1 2.8 -4.5 -3.7
PHR 2023-10-27 2.2 2.8 -4.5 -3.7

PHR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PHR has a Quality Grade of D, ranking ahead of 21% of graded US stocks.
  • PHR's asset turnover comes in at 0.404 -- ranking 372nd of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows PHR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-31 0.404 0.628 -0.958
2021-04-30 0.472 0.639 -0.563
2021-01-31 0.603 0.648 -0.474
2020-10-31 0.683 0.651 -0.415
2020-07-31 0.843 0.656 -0.373
2020-04-30 0.813 0.651 -0.432

PHR Price Target

For more insight on analysts targets of PHR, see our PHR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $73.50 Average Broker Recommendation 1.4 (Strong Buy)

Phreesia, Inc. (PHR) Company Bio

Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.

PHR Latest News Stream

Event/Time News Detail
Loading, please wait...

PHR Latest Social Stream

Loading social stream, please wait...

View Full PHR Social Stream

Latest PHR News From Around the Web

Below are the latest news stories about PHREESIA INC that investors may wish to consider to help them evaluate PHR as an investment opportunity.

Here’s Why Phreesia (PHR) Declined in Q3

Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […]

Yahoo | November 16, 2023

Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance

WILMINGTON, Del., November 08, 2023--Phreesia today announced its patient intake platform and data centers have earned certified status by HITRUST for information security.

Yahoo | November 8, 2023

Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains?

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | November 1, 2023

Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results

WILMINGTON, Del., November 01, 2023--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2024 financial results after the close of market trading on Tuesday, December 5, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at Phreesia will then hold a conference call to discuss its fiscal third quarter result

Yahoo | November 1, 2023

Insider Sell: Evan Roberts Sells 3,907 Shares of Phreesia Inc (PHR)

On September 13, 2023, Evan Roberts, the Chief Operating Officer (COO) of Phreesia Inc (NYSE:PHR), sold 3,907 shares of the company.

Yahoo | September 16, 2023

Read More 'PHR' Stories Here

PHR Price Returns

1-mo 16.33%
3-mo -47.24%
6-mo -51.33%
1-year -42.88%
3-year -64.02%
5-year N/A
YTD -50.90%
2022 -22.32%
2021 -23.22%
2020 103.68%
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!